Literature DB >> 12529051

Triggers for anti-chromatin autoantibody production in SLE.

J W C Dieker1, J van der Vlag, J H M Berden.   

Abstract

The formation of autoantibodies against chromatin is the main feature of systemic lupus erythematosis (SLE), an autoimmune disease, which is T-cell dependent and autoantigen-driven. Historically, antibodies against dsDNA, one of the components of chromatin, are considered as a hallmark of SLE. However, dsDNA is poorly immunogenic. Nucleosome-specific T helper cells have been identified. These T cells propagate not only nucleosome-specific antibodies, but also anti-dsDNA antibodies. Nucleosomes are formed during apoptosis by cleavage of chromatin, and evidence of disturbed apoptosis has been found especially in certain murine models of lupus. In addition to an increased rate of apoptosis, autoimmunity against chromatin might also result from an impaired phagocytosis of apoptotic material, for which strong evidence has been provided by studies in certain knock-out mice (C1q, SAP, Dnase I). The induction of an immune response to nucleosomes could be enhanced by modifications of histones or DNA during apoptosis, altered presentation by antigen presenting cells or a viral infection. The release of nucleosomes and the formation of anti-chromatin autoantibodies result in formation of complexes, which bind to the glomerular basement membrane via heparan sulfate. This deposition incites glomerulonephritis, the most serious manifestation of SLE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12529051     DOI: 10.1191/0961203302lu307rr

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  22 in total

Review 1.  A model for lupus brain disease.

Authors:  Betty Diamond; Bruce T Volpe
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens.

Authors:  Syamal K Datta; Li Zhang; Luting Xu
Journal:  J Mol Med (Berl)       Date:  2005-01-04       Impact factor: 4.599

3.  Antinucleosome antibodies in juvenile chronic arthritis.

Authors:  Renato M Nisihara; Thelma Skare; Marilia Barreto Silva; Rafael Mourato Silva; Danilo J Munhoz Silva
Journal:  Clin Rheumatol       Date:  2009-09-30       Impact factor: 2.980

Review 4.  The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved.

Authors:  Ole Petter Rekvig; Johan Van der Vlag
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

5.  A study on the association of autoantibodies, chemokine, and its receptor with disease activity in systemic lupus erythematosus in North Indian population.

Authors:  Leishangthem Bidyalaxmi Devi; Archana Bhatnagar; Ajay Wanchu; Aman Sharma
Journal:  Rheumatol Int       Date:  2013-07-06       Impact factor: 2.631

Review 6.  Epigenetic histone code and autoimmunity.

Authors:  Jürgen Dieker; Sylviane Muller
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

7.  A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone.

Authors:  Cecile Grootscholten; Jürgen W C Dieker; Fabian D McGrath; Anja Roos; Ronald H W M Derksen; Johan van der Vlag; Mohamed R Daha; Jo H M Berden
Journal:  Ann Rheum Dis       Date:  2006-11-29       Impact factor: 19.103

8.  DNase1 activity in systemic lupus erythematosus patients with and without nephropathy.

Authors:  Fernando Martinez-Valle; Eva Balada; Josep Ordi-Ros; Segundo Bujan-Rivas; Agustin Sellas-Fernandez; Miquel Vilardell-Tarres
Journal:  Rheumatol Int       Date:  2009-10-21       Impact factor: 2.631

9.  The effect of polyamines on the binding of anti-DNA antibodies from patients with SLE and normal human subjects.

Authors:  Xiao Wang; Nancy A Stearns; Xingfu Li; David S Pisetsky
Journal:  Clin Immunol       Date:  2014-04-13       Impact factor: 3.969

Review 10.  Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks.

Authors:  O P Rekvig
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.